Literature DB >> 11204046

Beta/Gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls.

M L Perlis1, M T Smith, P J Andrews, H Orff, D E Giles.   

Abstract

STUDY
OBJECTIVE: Several studies have shown that patients with insomnia exhibit elevated levels of Beta EEG activity (14-35 Hz) at or around sleep onset and during NREM sleep. In this study, we evaluated 1) the extent to which high frequency EEG activity is limited to the 14-32 Hz domain, 2) whether high frequency EEG activity (HFA) is associated with discrepancies between subjective and PSG measures of sleep continuity, and 3) the extent to which high frequency EEG activity occurs in patients with primary, as opposed to secondary, insomnia.
DESIGN: Three groups (n=9 per group) were compared: Primary Insomnia, Insomnia secondary to Major Depression, and Good Sleeper Controls. Groups were matched for age, sex and body mass. Average spectral profiles were created for each NREM cycle after removing waking and movement epochs and epochs containing micro- or mini-arousals.
SETTING: Sleep Research Laboratory PATIENTS OR PARTICIPANTS: Patients with primary and secondary insomnia
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: Subjects with Primary Insomnia exhibited more average NREM activity for Beta-1 (14-20Hz), Beta-2 (20-35Hz) and Gamma activity (35-45Hz) than the other two groups (p.<.01). Group differences were also suggestive for Omega activity (45.0-125Hz) (p.<.10), with MDD subjects tending to exhibit more activity than the other groups. Correlational analyses revealed that average NREM Beta-1 and Beta-2 activity tended to be negatively correlated with subjective-objective discrepancy measures for total sleep time and sleep latency.
CONCLUSIONS: Our results confirm that Beta activity is increased in Primary Insomnia. In addition, our data suggest that high frequency activity in patients with Primary Insomnia is limited to the Beta/Gamma range (14-45 Hz), and is negatively associated with the perception of sleep.

Entities:  

Mesh:

Year:  2001        PMID: 11204046     DOI: 10.1093/sleep/24.1.110

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  112 in total

1.  Enhanced frontoparietal synchronized activation during the wake-sleep transition in patients with primary insomnia.

Authors:  María Corsi-Cabrera; Pedro Figueredo-Rodríguez; Yolanda del Río-Portilla; Jorge Sánchez-Romero; Lídice Galán; Jorge Bosch-Bayard
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

2.  Sleep slow-wave activity regulates cerebral glycolytic metabolism.

Authors:  Jonathan P Wisor; Michael J Rempe; Michelle A Schmidt; Michele E Moore; William C Clegern
Journal:  Cereb Cortex       Date:  2012-07-05       Impact factor: 5.357

3.  EEG sleep spectra in older adults across all circadian phases during NREM sleep.

Authors:  Mirjam Münch; Edward J Silva; Joseph M Ronda; Charles A Czeisler; Jeanne F Duffy
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

4.  Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.

Authors:  Fabiana Fratello; Giuseppe Curcio; Michele Ferrara; Cristina Marzano; Alessandro Couyoumdjian; Giovanna Petrillo; Mario Bertini; Luigi De Gennaro
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

5.  Increased insular connectivity with emotional regions in primary insomnia patients: a resting-state fMRI study.

Authors:  Tianyue Wang; Jianhao Yan; Shumei Li; Wenfeng Zhan; Xiaofen Ma; Likun Xia; Meng Li; Chulan Lin; Junzhang Tian; Cheng Li; Guihua Jiang
Journal:  Eur Radiol       Date:  2017-01-31       Impact factor: 5.315

6.  History of the development of sleep medicine in the United States.

Authors:  John W Shepard; Daniel J Buysse; Andrew L Chesson; William C Dement; Rochelle Goldberg; Christian Guilleminault; Cameron D Harris; Conrad Iber; Emmanuel Mignot; Merrill M Mitler; Kent E Moore; Barbara A Phillips; Stuart F Quan; Richard S Rosenberg; Thomas Roth; Helmut S Schmidt; Michael H Silber; James K Walsh; David P White
Journal:  J Clin Sleep Med       Date:  2005-01-15       Impact factor: 4.062

7.  Insomnia: Prevalence, Impact, Pathogenesis, Differential Diagnosis, and Evaluation.

Authors:  Evelyn Mai; Daniel J Buysse
Journal:  Sleep Med Clin       Date:  2008

8.  Hyperarousal in insomnia and hypnotic dose escalation.

Authors:  T A Roehrs; T Roth
Journal:  Sleep Med       Date:  2016-07-06       Impact factor: 3.492

9.  Insomnia is Associated with Cortical Hyperarousal as Early as Adolescence.

Authors:  Julio Fernandez-Mendoza; Yun Li; Alexandros N Vgontzas; Jidong Fang; Jordan Gaines; Susan L Calhoun; Duanping Liao; Edward O Bixler
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

10.  Vulnerability to insomnia: the role of familial aggregation.

Authors:  Christopher L Drake; Holly Scofield; Thomas Roth
Journal:  Sleep Med       Date:  2007-09-06       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.